INVEX Therapeutics Ltd (IXC) — Financial Flexibility Index
INVEX Therapeutics Ltd (IXC) has a Financial Flexibility Index of -4.42x as of December 2025. Free cash flow of AU$-779.73K (operating CF AU$-779.73K minus capex AU$0.00) represents -4% of total liabilities (AU$176.49K). Check tangible equity quality of INVEX Therapeutics Ltd to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
INVEX Therapeutics Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for INVEX Therapeutics Ltd across 7 annual periods. For the full cash flow conversion analysis, see INVEX Therapeutics Ltd (IXC) cash flow conversion.
Annual Financial Flexibility Index for INVEX Therapeutics Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for INVEX Therapeutics Ltd. Explore INVEX Therapeutics Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.96x | AU$-652.57K | AU$-652.57K | AU$220.59K | ▲ +47.8% |
| 2024 | -5.66x | AU$-2.44 Million | AU$-2.44 Million | AU$431.63K | ▼ -29.6% |
| 2023 | -4.37x | AU$-6.87 Million | AU$-6.87 Million | AU$1.57 Million | ▼ -29.9% |
| 2022 | -3.36x | AU$-3.38 Million | AU$-3.38 Million | AU$1.00 Million | ▼ -32.0% |
| 2021 | -2.55x | AU$-1.68 Million | AU$-1.68 Million | AU$658.61K | ▼ -220.3% |
| 2020 | -0.80x | AU$-1.60 Million | AU$-1.60 Million | AU$2.02 Million | ▼ -235.3% |
| 2019 | -0.24x | AU$-221.94K | AU$-230.13K | AU$935.49K | — |